DNA ploidy of liver biopsies from patients with liver cirrhosis and hepatocellular carcinoma: A flow cytometric analysis

Cancer Letters

Volumn 142, Issue 1, 1999, Pages 65-69

  Attallah, Abdelfattah M ^a,b   Tabll, Ashraf A ^a   Salem, Samia F ^b   El Sadany, Mohamed ^b   Ibrahim, Talaat A ^b   Osman, Sanaa ^c   El Dosoky, Ibrahem M ^b  

^a Biotechnology Research Center of New Damietta   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Flow cytometry; Hepatocellular carcinoma; Liver cirrhosis; Ploidy

Indexed keywords

ARTICLE; CELL KINETICS; CONTROLLED STUDY; DYSPLASIA; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL;

ADULT; AGED; BIOPSY; CARCINOMA, HEPATOCELLULAR; DNA; FEMALE; FLOW CYTOMETRY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PLOIDIES;

EID: 0032974637     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00165-2     Document Type: Article

References (15)

1. Barwick K., Rosai J. Liver. Rosai J. Ackerman's Surgical Pathology, 8th ed. 2:1996;857 Mosby-Year Book.
2. Quinn C.M., Wright N.A. The clinical assessment proliferation and growth in human tumors: evaluation of methods and applications as prognostic variables. J. Pathol. 160:1990;93-102.
3. Shimamoto T., Sumii K. Usefulness of nucleolar organizer region staining in gastric myogenic tumor: correlation with ploidy by DNA flow cytometry. Oncology. 50:1993;52-56.
4. Chen M.F., Hwang T.L., Tsao K.C., Sun C.F., Chen T.J. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report. Surgery. 109:(4):1991;455-458.
5. Mise K., Tashiro S., Yogita S., Wada D., Harada M., Fukuda Y., Miyake H., Isikawa M., Izumi K., Sano N. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin. Cancer. Res. 4:(6):1998;1475-1482.
6. Kato A., Kubo K., Kurokawa K., Oga A., Murakami T. Numerical aberrations of chromosomes 16, 17 and 18 in hepatocellular carcinoma. Dig. Dis. Sci. 43:(1):1998;1-7.
7. Hayashi Y., Kanda N., Inaba T. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer. 63:1988;126-132.
8. Hiddeman W., Schumann J., Eef M. Convention on nomenclature for DNA cytometry. Cancer Genet. Cytogenet. 3:1984;181-183.
9. Raiker A., Green W., Shabaik A., Perlin E. Acute promyelocytic leukemia following treatment of non-Hodgkin's lymphoma. Cancer. 63:1989;1402-1406.
10. Maletz N., McMorrow L.E., Greco M.A., Wolman S.R. Ewing's sarcoma. Cancer. 58:1986;252-257.
11. Rua S., Comino A., Fruttero A., Torchio P., Bouzari H., Taraglio S., Torchio B., Capussotti L. Flow cytometric DNA analysis of cirrhotic cells in patients with hepatocellular carcinoma can provide a new prognostic factors. Cancer. 78:1996;1195-1202.
12. Anthony P.B. Liver cell dysplasia: what is its significance? Hepatology. 7:1987;394.
13. Tarao K., Ohkawa S., Shimizu A., Harada M., Nakamura Y., Ito Y. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from anti-hepatitis C virus positive cirrhotic patients. Cancer. 73:1994;1149-1154.
14. Ballardini G., Groff P., Zoli M. Increased risk of hepatocellular carcinoma development in patients with cirrhosis and with high hepatocellular proliferation. J. Hepatol. 20:1994;218.
15. Baker M.E., Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology. 97:1995;329-333.